These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2202464)

  • 41. How to improve therapy for adult acute myeloid leukemia: studies of the AML Cooperative Group in the Federal Republic of Germany.
    Büchner T; Hiddemann W; Maschmeyer G; Ludwig W; Löffler H; Nowrousian M; Aul C; Heinecke A
    J Cancer Res Clin Oncol; 1990; 116(1):97-9. PubMed ID: 2179230
    [No Abstract]   [Full Text] [Related]  

  • 42. Granulocyte-macrophage colony-stimulating factor with induction treatment of acute myelogenous leukemia.
    Adkins DR; Brown RA; DiPersio JF
    J Clin Oncol; 1997 Feb; 15(2):862-3. PubMed ID: 9053516
    [No Abstract]   [Full Text] [Related]  

  • 43. Granulocyte-macrophage colony-stimulating factor: a teaching program for staff and patients.
    Woolery-Antill M
    J Pediatr Oncol Nurs; 1990 Apr; 7(2):61. PubMed ID: 2194506
    [No Abstract]   [Full Text] [Related]  

  • 44. GM-CSF treatment and hypokalemia.
    Viens P; Thyss A; Garnier G; Ayela P; Lagrange M; Schneider M
    Ann Intern Med; 1989 Aug; 111(3):263. PubMed ID: 2665594
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemotherapy and the circulating progenitor cell compartment.
    Reid CD; Kirk A; Chanarin I
    Lancet; 1988 Aug; 2(8609):518-9. PubMed ID: 2900451
    [No Abstract]   [Full Text] [Related]  

  • 46. GM-CSF and ganciclovir for cytomegalovirus infection after autologous bone-marrow transplantation.
    Fouillard L; Gorin NC; Laporte JP; Eugene-Jolchine I; Isnard F; Najman A
    Lancet; 1989 Nov; 2(8674):1273. PubMed ID: 2573779
    [No Abstract]   [Full Text] [Related]  

  • 47. Myeloid growth factors in acute myeloid leukemia: systematic review of randomized controlled trials.
    Heuser M; Zapf A; Morgan M; Krauter J; Ganser A
    Ann Hematol; 2011 Mar; 90(3):273-81. PubMed ID: 20838825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.
    Edmonson JH; Long HJ; Jeffries JA; Buckner JC; Colon-Otero G; Fitch TR
    J Natl Cancer Inst; 1989 Oct; 81(19):1510-2. PubMed ID: 2674462
    [No Abstract]   [Full Text] [Related]  

  • 49. Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials.
    Sung L; Alibhai SM; Beyene J; Gamis A; Almeida R; Smith S; Aplenc R
    Leukemia; 2009 Apr; 23(4):811-3. PubMed ID: 18987652
    [No Abstract]   [Full Text] [Related]  

  • 50. Enhancement of alloimmunization: a potential hazard of GM-CSF treatment in patients with severe aplastic anemia?
    Kuentz M; Bierling P; Norolle F; Cordonnier C; Rochant H; Vernant JP
    Transfusion; 1989 Sep; 29(7):654-5. PubMed ID: 2672436
    [No Abstract]   [Full Text] [Related]  

  • 51. Granulocyte-macrophage colony-stimulating factor and vasculitis.
    Dreicer R; Schiller JH; Carbone PP
    Ann Intern Med; 1989 Jul; 111(1):91-2. PubMed ID: 2660649
    [No Abstract]   [Full Text] [Related]  

  • 52. [Granulocytopoietic effect of human urinary colony-stimulating factor on prolonged granulocytopenia after cancer chemotherapy (clinical phase III study)].
    Motoyoshi K; Takaku F; Masaoka T; Miyazaki T; Shibata A; Omine M; Kimura K; Miura Y; Furusawa S; Abe T
    Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2760-8. PubMed ID: 3074145
    [No Abstract]   [Full Text] [Related]  

  • 53. Recombinant human granulocyte-macrophage colony-stimulating factor produces fever.
    Peters WP; Shogan J; Shpall EJ; Jones RB; Kim CS
    Lancet; 1988 Apr; 1(8591):950. PubMed ID: 2895883
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study on protective effect of Shenmai injection on hematopoiesis of bone marrow in acute leukemia patients with chemotherapy].
    Wang JY; Zhong XM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Mar; 25(3):266-7. PubMed ID: 15842155
    [No Abstract]   [Full Text] [Related]  

  • 55. Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.
    Ramsey SD; McCune JS; Blough DK; McDermott CL; Clarke L; Malin JL; Sullivan SD
    Am J Manag Care; 2010 Sep; 16(9):678-86. PubMed ID: 20873955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complete, yet partial: the benefits of complete response with partial haematological recovery as an endpoint in acute myeloid leukaemia clinical trials.
    Shallis RM; Pollyea DA; Zeidan AM
    Lancet Haematol; 2020 Dec; 7(12):853-856. PubMed ID: 33242436
    [No Abstract]   [Full Text] [Related]  

  • 57. Hematopoietic growth factors: colony stimulating factors.
    Advani SH
    Indian J Med Sci; 1994 Feb; 48(2):47-53. PubMed ID: 8045631
    [No Abstract]   [Full Text] [Related]  

  • 58. Targeted plasma drug concentration: a new therapeutic approach to relapsed nonlymphoblastic leukemia in children.
    Mirro J; Crom WR; Kalwinsky DK; Santana VM; Baker DK; Belt J
    Haematol Blood Transfus; 1989; 32():82-7. PubMed ID: 2696694
    [No Abstract]   [Full Text] [Related]  

  • 59. Hematopoietic growth factors and in vitro growth of human acute myeloblastic leukemia.
    Löwenberg B; Delwel R; Touw I
    Crit Rev Oncol Hematol; 1990; 10(1):1-8. PubMed ID: 2183810
    [No Abstract]   [Full Text] [Related]  

  • 60. Acute-phase response in patients given rhIL-3 after chemotherapy.
    Khwaja A; Choppa R; Goldstone AH; Linch DC
    Lancet; 1992 Jun; 339(8809):1617. PubMed ID: 1351593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.